RxDoctor Payments Data

Laura Bradel

Elmira, NYNPI 1962963967

Payments from drug & device makers

What this record shows

This record is dominated by grants: $32,500 of the $48,382 with a category attached, or 67.2%. 11 manufacturers reported payments, led by Abbott at 36.9% of the total. 2025 is the largest year on record at $42,564, more than ten times the $137 reported in 2022.

$48,382in general payments, 2019–2025

Across 174 payments — averaging $278.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$18K
  • Boston Scientific$14K
  • Medtronic$14K
  • Boehringer Ingelheim$828
  • Abiomed$425
  • AstraZeneca$395
  • plus $827 from 5 others

What the payments were for

  • Grants$32,50067%
  • Travel & lodging$7,16915%
  • Food & beverage$8,63018%
  • Education$830%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →